United Therapeutics (UTHR), DEKA Report Additional FDA Clearance Related to Unity Subcutaneous Delivery System for Remodulin

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. NKE
8. MU
9. PFE
10. AWK

Go back to United Therapeutics (UTHR), DEKA Report Additional FDA Clearance Related to Unity Subcutaneous Delivery System for Remodulin

United Therapeutics and DEKA Announce Additional FDA Clearance Related to the Unity Subcutaneous Delivery System for Remodulin®

February 24, 2020 6:16 AM EST

RESEARCH TRIANGLE PARK, N.C. and MANCHESTER, N.H., Feb. 24, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) and DEKA Research & Development Corp. today announced receipt of an additional 510(k) clearance by the U.S. Food and Drug Administration (FDA) related to the Unity Subcutaneous Delivery System for Remodulin® (treprostinil) Injection, also referred to as the Remunity pump, enabling United Therapeutics to launch the system using drug reservoirs that have been prefilled by specialty pharmacies.

... More